ANSWER # 1 PHARMACOLOGY. Methadone answers Stoltzfus 4/5/2012 METHADONE: WHY GRANDMA S TAKING A DIPHENYLHEPTANE (ANSWERS) JANUARY 26, 2017

Size: px
Start display at page:

Download "ANSWER # 1 PHARMACOLOGY. Methadone answers Stoltzfus 4/5/2012 METHADONE: WHY GRANDMA S TAKING A DIPHENYLHEPTANE (ANSWERS) JANUARY 26, 2017"

Transcription

1 METHADONE: WHY GRANDMA S TAKING A DIPHENYLHEPTANE (ANSWERS) JANUARY 26, 2017 Ky Stoltzfus, MD Assistant Professor, Internal Medicine University of Kansas Medical Center ANSWER # 1 Your response might be that it acts on the mu opioid receptors and: 1. Kappa receptors 2. Neurokinin receptors 3. NMDA receptors 4. GABA receptors PHARMACOLOGY Acts on mu and NMDA receptors 80-90% oral bioavailability Lipophilic No active metabolites and biotransformation to an active drug is not required Half life: hours Duration of analgesia: 6-12 hours 1

2 ANSWER #2 You astutely respond, It s not a good idea to use it in patients: 1. With renal failure 2. With liver failure 3. Older than 65 years old 4. Who have a prior history of drug abuse PHARMACOLOGY Metabolized primary by liver with fecal excretion Metabolized by cytochrome P450 3A4 Important because of drug-drug interactions. QUESTION # 3 CONTINUED He developed some dysphagia and was noted by the home nurse to have white plaques in his oropharynx and you prescribed fluconazole about 3 days ago for candida esophagitis. His wife started cooking with a lot of turmeric recently because she heard it is a natural anti-cancer drug. Upon visiting him today you note that he s become very lethargic and has a slightly slowed respiratory rate at about 8-10 breaths/minute. His wife reports that he s been more lethargic over the past few days. 2

3 ANSWER #3 You think it may be one his medications causing this, what would you consider first: 1. Buproprion 2. Timolol 3. Fluconazole 4. Turmeric DRUG INTERACTIONS Agents That May INCREASE Serum Methadone Concentrations Antidepressants: SSRIs, amitriptyline Antifungals: fluconazole, ketoconazole, posaconazole ANSWER # 4 You decide to discontinue: 1. Metoprolol 2. Risperdone 3. Ceftriaxone 4. Hydrocortisone ointment 3

4 MORE DRUG INTERACTIONS Agents That May DECREASE Serum Methadone Concentrations Antiepileptics: carbamazepine, phenobarbital, phenytoin Antipsychotics: risperidone Antiretrovirals: nevirapine, ritonavir Antitubercular: rifampin Other: St. John s Wort CONTRAINDICATED Cisapride (Propulsid) Quinidine Dronedarone (Multaq) MAOIs Phenothiazines: chlorpromazine (Thorazine), procholpromazine (Compazine), promethazine (Phenergan) Ziprasidone (Geodon) THE BOTTOM LINE Be alert and aware of patients on Methadone and: Cardiac meds Antiretrovirals Psych meds Nausea meds 4

5 SAFETY High caution in patients with liver dysfunction. No dose adjustment for patients with renal failure. However, two prospective studies on methadone excluded patients with kidney and liver disease. 1,2 Patients older than 65 years old have decreased clearance of methadone Ripamonti C, Switching from morphine to oral methadone. 2. Mercadante S, Switching from morphine to methadone. 3. Plummer JL, Estimation of methadone clearance. ANSWER # 5 You reply: 1. Above 300 ms 2. Above 440 ms 3. Above 500 ms 4. Oh, I didn t know we should check an EKG. RECOMMENDATIONS FOR SAFELY STARTING Disclosure: inform patient of arrhythmia risk Clinical History: screen history of structural heart disease, arrhythmia, & syncope Screening: EKG, baseline QTc, 30 day, annually. Additional EKGs if using >100mg/day or unexplained syncope or seizures. 5

6 RECOMMENDATIONS FOR SAFELY STARTING (CONTINUED) Risk Stratification: If QTc is ms: discuss risk/benefit, closer monitoring If >500 ms: consider discontinuing or reducing avoid hypokalemia consider alternative therapy Drug Interaction: be aware of methadonedrug interactions Dose reduce by 50% for patients older than 65yo STARTING METHADONE Opioid naïve: Counsel patient Check EKG Look for drug-drug interactions Start 1 2.5mg PO/PR every 8 hours Titrate every 5-7 days ALTERNATIVE STARTING DOSE (NAÏVE PATIENT) Begin fixed dose methadone 5 or 10 mg orally bid or tid for 4-7 days. If incomplete pain relief, increase the dose by 50% and continue for 4-7 days. Continue increasing dose every 4-7 days until stable pain relief achieved. Breakthrough pain: use an alternative short acting oral opioid with short half-life (e.g. morphine 10 mg) every 1 h PRN for breakthrough pain and to provide pain relief during titration phase. This dose too may need to be titrated based on efficacy. Von Gunten C, Fast Fact # 86 6

7 ONE MORE ALTERNATIVE (NAÏVE PATIENT) Load: Start methadone at fixed oral dose (e.g. 5 or 10 mg) q 4h PRN only. Calculate Maintenance: On day 8, calculate the total methadone dosage taken over the last 24 hour period and give that in scheduled, divided doses bid or tid. Give 10% of total daily methadone as PRN drug q1h for breakthrough pain. Instruct the patient to call you if they need to use more than 5 breakthrough doses per day. Example: if someone took a total of 45 mg methadone on day 7 they would be converted to 15 mg tid scheduled with 5 mg as the prn dose. Von Gunten C, Fast Fact # 86 OPIOID TOLERANT PATIENTS (AKA THIS AINT MY FIRST RODEO) Stop & Go approach Stop all opioids then start Methadone Reduce & Replace Reduce by 30% each day over 3 days REDUCE AND REPLACE Day 1 Decrease previous opioid usage by 1/3 Replace with 3% of previous daily oral morphine equivalent dosage, given as PO/PR every 8 hours Day 2 Decrease previous opioid usage by 1/3 if pain is controlled with rescue short-acting opioid Increase Methadone dosage only if pain is moderate to severe Day 3 Discontinue final 1/3 of previous opioid For breakthrough pain, give rescue dose of ~10% daily methadone dose PO/PR Continue daily assessment of pain and dose titration until effective stable dose of methadone reached Bruera E. Role of Methadone. 7

8 HOW TO CONVERT First, be aware it s complex and use reference materials Second, check your work Third, double check your work Fourth, consider asking a colleague to double check your work A physician, ARNP, pharmacist ANSWER # 6 MS Contin 300mg MS IR 180mg Total 480mg 1 st day: 320mg oral morphine (66% of previous) 15mg Methadone 5mg TID (3% of OME) Target dose: ~45mg Methadone 15mg TID (over 3 days) ANSWER # 7 Hydromorphone basal: 72mg in 24hrs (3mg x 24) demand: 24mg in 24hrs (1mg x 24) TOTAL: 96mg in 24hrs Convert to OME: x / 96 = 30 / 1.5 x = 1920mg OME (30 : 1.5 conversion IV Dilaudid to PO Morphine) First day: change basal to 2mg/hr (33% reduction), keep demand same, start Methadone 50-60mg per day (3% of OME) Target: ~96mg Methadone per day (using 1:20 ratio) 8

9 REVIEW Methadone has good opioid and neuropathic pain activity Keep safety in mind When starting or converting to methadone: Discuss risks/benefits with the patient Look for potential interactions Check and double check your math 9

Opioid Pearls and Acute Pain Management

Opioid Pearls and Acute Pain Management Opioid Pearls and Acute Pain Management Jeanie Youngwerth, MD University of Colorado Denver Assistant Professor of Medicine, Hospitalist Associate Director, Colorado Palliative Medicine Fellowship Program

More information

Overview of Essentials of Pain Management. Updated 11/2016

Overview of Essentials of Pain Management. Updated 11/2016 0 Overview of Essentials of Pain Management Updated 11/2016 1 Overview of Essentials of Pain Management 1. Assess pain intensity on a 0 10 scale in which 0 = no pain at all and 10 = the worst pain imaginable.

More information

Managing Pain: A Focus on the Appropriate Use of Methadone

Managing Pain: A Focus on the Appropriate Use of Methadone Managing Pain: A Focus on the Appropriate Use of Methadone Karla Anderson, PharmD Regional Client Liaison Anthony Contreras, RPh Regional Sales Associate Hospice Pharmacia, a division of excellerx, Inc.

More information

Equianalgesic Dosing: Making Opioid Interchange Easier. Joseph Bubalo PharmD, BCPS, BCOP Oncology Clinical Pharmacist Assistant Professor Of Medicine

Equianalgesic Dosing: Making Opioid Interchange Easier. Joseph Bubalo PharmD, BCPS, BCOP Oncology Clinical Pharmacist Assistant Professor Of Medicine Equianalgesic Dosing: Making Opioid Interchange Easier Joseph Bubalo PharmD, BCPS, BCOP Oncology Clinical Pharmacist Assistant Professor Of Medicine 1 Why Change Opioids? Side Effects Insufficient Pain

More information

Methadone: Essential Hospice Analgesic or Too Risky for Prime Time?

Methadone: Essential Hospice Analgesic or Too Risky for Prime Time? Methadone Background Methadone: Essential Hospice Analgesic or Too Risky for Prime Time? Developed originally as an antispasmodic and later used as an analgesic, starting in late 1940 s Used extensively

More information

Pain Management Management in Hepatic Hepatic and and Renal Dysfunction

Pain Management Management in Hepatic Hepatic and and Renal Dysfunction Pain Management in Hepatic and Renal Dysfunction Review the pharmacologic basis for medications used in pain management Identify pain medications which hshould ldbe avoided in patients with hepatic dysfunction

More information

Methadone Maintenance

Methadone Maintenance Methadone Maintenance A Practical Guide to Pharmacotherapy Methadone/Buprenorphine 101 Workshop, April 1, 2017 Ron Joe, MD, DABAM Objectives I. Pharmacology Of Methadone II. Practical Application of Pharmacology

More information

Pain management. Coleman Palliative Care Conference: February 2016 Josh Baru MD Stacie Levine MD

Pain management. Coleman Palliative Care Conference: February 2016 Josh Baru MD Stacie Levine MD Pain management Coleman Palliative Care Conference: February 2016 Josh Baru MD Stacie Levine MD Case #1 61 yo man with history of Stage 3 colon cancer, s/p resection and adjuvant chemotherapy with FOLFOX

More information

Opioid Use in Serious Illness

Opioid Use in Serious Illness Opioid Use in Serious Illness Jeanie Youngwerth, MD University of Colorado School of Medicine Associate Professor of Medicine, Hospitalist Director, Palliative Care Service Associate Director, Colorado

More information

Fighting the Good Fight: How to Convert Opioids Just Right!

Fighting the Good Fight: How to Convert Opioids Just Right! Fighting the Good Fight: How to Convert Opioids Just Right! Tanya J. Uritsky, PharmD, BCPS, CPE Clinical Pharmacy Specialist - Pain Medication Stewardship Hospital of the University of Pennsylvania - Philadelphia,

More information

Opioid Conversions Mixture of Science and Art

Opioid Conversions Mixture of Science and Art Opioid Conversions Mixture of Science and Art Matthew J. Pingree, MD Assistant Professor Division of Pain Medicine Physical Medicine and Rehabilitation and Anesthesiology Mayo Clinic, Rochester Pingree.Matthew@Mayo.edu

More information

Long Term Care Formulary HCD - 08

Long Term Care Formulary HCD - 08 1 of 5 PREAMBLE Opioids are an important component of the pharmaceutical armamentarium for management of chronic pain. The superiority of analgesic effect of one narcotic over another is not generally

More information

Appendix D: Drug Tables

Appendix D: Drug Tables Appendix D: Drug Tables A. Short-acting, Orally Administered Opioids Table D-1: Use of Short-acting, Orally Administered Opioids in Adults [198] Additional Maximum APAP dose: 4000 mg/d (2000 mg/d in chronic

More information

PAIN MANAGEMENT PGY-1. Aaron D. Storms, MD Carin van Zyl, MD Adult and Pediatric Palliative Care, LAC+USC Keck School of Medicine of USC

PAIN MANAGEMENT PGY-1. Aaron D. Storms, MD Carin van Zyl, MD Adult and Pediatric Palliative Care, LAC+USC Keck School of Medicine of USC PAIN MANAGEMENT PGY-1 Aaron D. Storms, MD Carin van Zyl, MD Adult and Pediatric Palliative Care, LAC+USC Keck School of Medicine of USC Perception Matters A builder aged 29 came to the accident and emergency

More information

Objectives. Disclosure. Opioid Adverse Effects. Strategies for Monitoring and Reducing Opioid Related Oversedation 7/25/2013

Objectives. Disclosure. Opioid Adverse Effects. Strategies for Monitoring and Reducing Opioid Related Oversedation 7/25/2013 Strategies for Monitoring and Reducing Opioid Related Oversedation Mitchell Nazario, PharmD, CPE Clinical Pain Specialist West Palm Beach VA Medical Center Pharmacy Service (119) 7305 N. Military Trail

More information

Appendix 1. University of Minnesota Amplatz Children s Hospital Opioid Weaning Guideline

Appendix 1. University of Minnesota Amplatz Children s Hospital Opioid Weaning Guideline Appendix 1. University of Minnesota Amplatz Children s Hospital Opioid Weaning Guideline 1. Pharmacist to order Narcotic Withdrawal Scores QH X 4 hours, then per table below: Narcotic Withdrawal Score

More information

2-ethylidene-1,5-dimethyl-3,3diphenylpyrrolidene (EDDP) Safe in stable liver disease Long acting

2-ethylidene-1,5-dimethyl-3,3diphenylpyrrolidene (EDDP) Safe in stable liver disease Long acting 2012 AAHPM & HPNA Annual Assembly March 7-10, 2012 Denver, CO Methadone the Taming of the Shrew Stefan J. Friedrichsdorf, M.D. Medical Director Department of Pain Medicine, Palliative Care & Integrative

More information

Ketamine and Methadone Supra- Regional Audit Presentation

Ketamine and Methadone Supra- Regional Audit Presentation Ketamine and Methadone Supra- Regional Audit Presentation Audit Group: Alison Coackley, Anthony Thompson, Graham Whyte, Helen Bonwick, Ruth Clark, Agnes Noble, Aileen Scott, Andrew Dickman, Sarah Fradsham

More information

To Dream The Impossible Dream: Acute Pain Management for Patients on Buprenorphine

To Dream The Impossible Dream: Acute Pain Management for Patients on Buprenorphine To Dream The Impossible Dream: Acute Pain Management for Patients on Buprenorphine Tanya J. Uritsky, PharmD, BCPS, CPE Disclosure Nothing to disclose 1 Learning Objectives Describe how the pharmacokinetic

More information

4/3/2018. Management of Acute Pain Crises. Five Mistakes I ve made and why you shouldn t

4/3/2018. Management of Acute Pain Crises. Five Mistakes I ve made and why you shouldn t Management of Acute Pain Crises Maggie O Connor, M.D. Retired Palliative Care Physician Hope is not the conviction that something will turn out well, but the certainty that something makes sense, regardless

More information

Ketamine and Methadone Supra- Regional Audit Presentation

Ketamine and Methadone Supra- Regional Audit Presentation Ketamine and Methadone Supra- Regional Audit Presentation Audit Group: Alison Coackley, Anthony Thompson, Graham Whyte, Helen Bonwick, Ruth Clark, Agnes Noble, Aileen Scott, Andrew Dickman, Sarah Fradsham

More information

PAIN. TREATMENT TABLES Analgesics. NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose

PAIN. TREATMENT TABLES Analgesics. NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose NON-OPIOID SHORT-ACTING LONG-ACTING **** O PAIN TREATMENT TABLES Analgesics NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose Tramadol 50 mg Ultram Every 4 hours 1-2 tabs,

More information

Opioid Rotation. Dr Bruno Gagnon, M.D., M.Sc.

Opioid Rotation. Dr Bruno Gagnon, M.D., M.Sc. Opioid Rotation Dr Bruno Gagnon, M.D., M.Sc. Associate Professor Department of Family Medicine and Emergency Medicine, Faculty of Medicine, Université Laval Consultant in Palliative Medicine CHU de Québec-Université

More information

Opioid Case Studies. Thomas P. Pittelkow, D.O., M.P.H. Mayo Clinic College of Medicine Rochester, MN. September 29, MFMER slide-1

Opioid Case Studies. Thomas P. Pittelkow, D.O., M.P.H. Mayo Clinic College of Medicine Rochester, MN. September 29, MFMER slide-1 Opioid Case Studies Thomas P. Pittelkow, D.O., M.P.H. Mayo Clinic College of Medicine Rochester, MN September 29, 2016 2015 MFMER slide-1 Disclosures Relevant Financial Relationship(s) None Off Label and/or

More information

15mg oxycodone is equivalent to how much morphine

15mg oxycodone is equivalent to how much morphine 15mg oxycodone is equivalent to how much morphine The Borg System is 100 % 15mg oxycodone is equivalent to how much morphine nursing home activity director cover letter 15 mg oxycodone equal to how much

More information

FENTANYL CITRATE TRANSMUCOSAL UTILIZATION MANAGEMENT CRITERIA

FENTANYL CITRATE TRANSMUCOSAL UTILIZATION MANAGEMENT CRITERIA FENTANYL CITRATE TRANSMUCOSAL UTILIZATION MANAGEMENT CRITERIA DRUG CLASS: BRAND (generic) NAMES: HICL = H3AT Fentanyl citrate transmucosal Actiq (fentanyl citrate) lozenge on a handle 200, 400, 600, 800,

More information

Approach to Acute Pain Management

Approach to Acute Pain Management Approach to Acute Pain Management Jeanie Youngwerth, MD University of Colorado School of Medicine Associate Professor of Medicine, Hospitalist Director, Palliative Care Service Associate Director, Colorado

More information

IF I M NOT TREATING WITH OPIOIDS, THEN WHAT AM I SUPPOSED TO USE?

IF I M NOT TREATING WITH OPIOIDS, THEN WHAT AM I SUPPOSED TO USE? NON-OPIOID TREATMENT OPTIONS FOR CHRONIC PAIN Alison Knutson, PharmD, BCACP Medication Management Pharmacist Park Nicollet Creekside Clinic Dr. Knutson indicated no potential conflict of interest to this

More information

Demystifying Opioid Conversion Calculations

Demystifying Opioid Conversion Calculations Demystifying Opioid Conversion Calculations Stephanie Cheng, PharmD, MPH, BCGP Clinical Pharmacist Hospice Pharmacy Solutions November 28, 2018 Learning Objectives After this presentation, you should be

More information

What to do when you are called to see a patient with... PAIN. Susan Merel, MD Division of General Internal Medicine July 2018

What to do when you are called to see a patient with... PAIN. Susan Merel, MD Division of General Internal Medicine July 2018 What to do when you are called to see a patient with... PAIN Susan Merel, MD Division of General Internal Medicine July 2018 Disclosures Susan Merel has no relationships with any entity producing, marketing,

More information

Medications for the Treatment of Neuropathic Pain

Medications for the Treatment of Neuropathic Pain Medications for the Treatment of Neuropathic Pain February 23, 2011 Jinny Tavee, MD Associate Professor Neurological Institute Cleveland Clinic Foundation Neuropathic Pain Pain, paresthesias, and sensory

More information

Acute Pain Management in the Hospital Setting. Alexandra Phan, PharmD PGY-1 Pharmacy Practice Resident Medical Center Hospital Odessa, TX

Acute Pain Management in the Hospital Setting. Alexandra Phan, PharmD PGY-1 Pharmacy Practice Resident Medical Center Hospital Odessa, TX Acute Pain Management in the Hospital Setting Alexandra Phan, PharmD PGY-1 Pharmacy Practice Resident Medical Center Hospital Odessa, TX 2 What is Pain? An unpleasant sensory and emotional experience associated

More information

CHAMP: Bedside Teaching TREATING PAIN. Stacie Levine MD. What is the approach to treating pain in the aging adult patient?

CHAMP: Bedside Teaching TREATING PAIN. Stacie Levine MD. What is the approach to treating pain in the aging adult patient? CHAMP: Bedside Teaching TREATING PAIN Stacie Levine MD Teaching Trigger: An older adult patient is identified as having pain. Clinical Question: What is the approach to treating pain in the aging adult

More information

Chronic Pain Pharmacist role in the clinic

Chronic Pain Pharmacist role in the clinic Chronic Pain Pharmacist role in the clinic WSPA Annual Meeting 2015 Alvin Goo, PharmD Clinical Associate Professor University of Washington Schools of Pharmacy and Family Medicine Speakers Declaration

More information

Symptom Management Challenges at End-of-Life

Symptom Management Challenges at End-of-Life Symptom Management Challenges at End-of-Life Amanda Lovell, PharmD, BCGP Clinical Pharmacist- Inpatient Units Optum Hospice Pharmacy Services February 15, 2018 Hospice Pharmacy Services Objectives Identify

More information

10 mg hydrocodone equals how much oxycodone

10 mg hydrocodone equals how much oxycodone Cari untuk: Cari Cari 10 mg hydrocodone equals how much oxycodone Posts about dilaudid 8 vs oxycodone 30 written by buyprescriptionmedication. Can you help me with the conversion of Oxycodone IR (5mg tab)

More information

Morphine er to oxycontin conversion

Morphine er to oxycontin conversion Morphine er to oxycontin conversion The Borg System is 100 % Morphine er to oxycontin conversion 17-4-2011 Conversion dose from Oxycontin 40mg 3x a day to morphine sulfate 15 mg?. Oxycontin vs morphine

More information

Conversion from oxycodone to ms contin

Conversion from oxycodone to ms contin Search for: Search Search Conversion from oxycodone to ms contin Opioid Dose Converter. Enter 24-hour total doses below, then click the convert button to display 24-hour equianalgesic. Oxycodone SC. mg.

More information

Jim McGregor MD. What s New in Pain and Symptom Management. CAHSAH CHAPCA Annual Conference & Expo May 22 24, 2018, Monterey, CA

Jim McGregor MD. What s New in Pain and Symptom Management. CAHSAH CHAPCA Annual Conference & Expo May 22 24, 2018, Monterey, CA What s New in Pain and Symptom Management Jim McGregor MD Play the 2018 Conference Post to Win Game for a chance to win different prizes each day! 1 Objectives Describe patients who are appropriate for

More information

Po dilaudid versus iv dilaudid

Po dilaudid versus iv dilaudid Po dilaudid versus iv dilaudid Search IM/IV/SC 120 mg ratios of morphine to methadone in patients with neuropathic pain versus non-neuropathic an equianalgesic ratio for PO. Dilaudid official prescribing

More information

Domain 1 Pharmacokinetic and pharmacodynamics properties of methadone

Domain 1 Pharmacokinetic and pharmacodynamics properties of methadone Methadone Survey Knowledge Domains: Domain 1 Pharmacokinetic and pharmacodynamics properties of methadone Domain 2 Appropriate/inappropriate candidates for methadone Domain 3 Risk stratification with methadone

More information

Analgesics: Management of Pain In the Elderly Handout Package

Analgesics: Management of Pain In the Elderly Handout Package Analgesics: Management of Pain In the Elderly Handout Package Analgesics: Management of Pain in the Elderly Each patient or resident and their pain problem is unique. A complete assessment should be performed

More information

1/21/14. Cancer Related Pain: Case-Based Pharmacology. Conflicts of Interest. Learning Objective

1/21/14. Cancer Related Pain: Case-Based Pharmacology. Conflicts of Interest. Learning Objective Cancer Related Pain: Case-Based Pharmacology Jeannine M. Brant, PhD, APRN, AOCN Oncology Clinical Nurse Specialist Nurse Scientist Billings Clinic Conflicts of Interest Jeannine Brant has served on the

More information

Pain Management Dilemmas. Five Pain Dilemmas. Barriers: Meet Loretta. Daniel Johnson, MD, FAAHPM

Pain Management Dilemmas. Five Pain Dilemmas. Barriers: Meet Loretta. Daniel Johnson, MD, FAAHPM Pain Management Dilemmas Daniel Johnson, MD, FAAHPM Kaiser Permanente University of Colorado Five Pain Dilemmas 1. Barriers to Pain Management 2. Selecting and Titrating Opioids 3. Managing PCAs 4. Using

More information

B. Long-acting/Extended-release Opioids

B. Long-acting/Extended-release Opioids 4 Opioid tolerance is assumed in patients already taking fentanyl 25 mcg/hr OR daily doses of the following oral agents for 1 week: 60 mg oral morphine, 30 mg oxycodone, 8 mg hydromorphone, 25 mg of oxymorphone

More information

Nuplazid. (pimavanserin) New Product Slideshow

Nuplazid. (pimavanserin) New Product Slideshow Nuplazid (pimavanserin) New Product Slideshow Introduction Brand name: Nuplazid Generic name: Pimavanserin Pharmacological class: Atypical antipsychotic Strength and Formulation: 17mg; tablets Manufacturer:

More information

Odefsey. (emtricitabine, rilpivirine, tenofovir alafenamide) New Product Slideshow

Odefsey. (emtricitabine, rilpivirine, tenofovir alafenamide) New Product Slideshow Odefsey (emtricitabine, rilpivirine, tenofovir alafenamide) New Product Slideshow Introduction Brand name: Odefsey Generic name: Emtricitabine, rilpivirine, tenofovir alafenamide (TAF) Pharmacological

More information

BACKGROUND Measuring renal function :

BACKGROUND Measuring renal function : A GUIDE TO USE OF COMMON PALLIATIVE CARE DRUGS IN RENAL IMPAIRMENT These guidelines bring together information and recommendations from the Palliative Care formulary (PCF5 ) BACKGROUND Measuring renal

More information

Objectives. Patient Controlled Analgesia (PCA) Management in the Seriously Ill. Discuss principles for opioid dosing and titration for acute pain

Objectives. Patient Controlled Analgesia (PCA) Management in the Seriously Ill. Discuss principles for opioid dosing and titration for acute pain Patient Controlled Analgesia (PCA) Management in the Seriously Ill Jeanie Youngwerth, MD University of Colorado School of Medicine Associate Professor of Medicine, Hospitalist Associate Director, Colorado

More information

Session II. Learning Objectives for Session II. Key Principles of Safe Prescribing. Benefits and Limitations of ER/LA Opioids

Session II. Learning Objectives for Session II. Key Principles of Safe Prescribing. Benefits and Limitations of ER/LA Opioids Learning Objectives for Session II Session II Best Practices for How to Start Therapy with ER/LA Opioids, How to Stop, and What to Do in Between Upon completion of this module, the participants will be

More information

Dsuvia (sufentanil) NEW PRODUCT SLIDESHOW

Dsuvia (sufentanil) NEW PRODUCT SLIDESHOW Dsuvia (sufentanil) NEW PRODUCT SLIDESHOW Introduction Brand name: Dsuvia Generic name: Sufentanil Pharmacological class: Opioid agonist Strength and Formulation: 30mcg; sublingual tabs (housed in a disposable,

More information

Palliative Emergencies. Ken Stakiw

Palliative Emergencies. Ken Stakiw Palliative Emergencies Ken Stakiw Disclosure None to disclose for this lecture Have received honoraria from a number of agencies and companies previously Intend to discuss some off label use of medications

More information

BASICS OF OPIOID PRESCRIBING 10:30-11:45AM

BASICS OF OPIOID PRESCRIBING 10:30-11:45AM PROVIDING QUALITY CARE TO PAIN PATIENTS IN IOWA BASICS OF OPIOID PRESCRIBING 10:30-11:45AM ACPE UAN: 107-000-14-013-L01-P Activity Type: Application-Based 0.125 CEU/1.25hr Learning Objectives for Pharmacists:

More information

Opioid Pain Management. John Manfredonia, DO. Disclosures. Dr. Manfredonia discloses his employment as Regional Medical Director for VistaCare

Opioid Pain Management. John Manfredonia, DO. Disclosures. Dr. Manfredonia discloses his employment as Regional Medical Director for VistaCare Opioid Pain Management John Manfredonia, DO Disclosures Dr. Manfredonia discloses his employment as Regional Medical Director for VistaCare VistaCare has provided commercial support for this activity Palliative

More information

Multiple Choice Questions

Multiple Choice Questions Multiple Choice Questions 25yo M presents without psychiatric or medical history, with complaint of tremor to the ER. He denies drinking alcohol but his friend at bedside takes you to the side and reports

More information

Tips for Managing Acute Pain

Tips for Managing Acute Pain Tips for Managing Acute Pain Daniel Johnson, MD, FAAHPM Kaiser Permanente University of Colorado Session Outline 1. Pseudoaddiction 2. Opioid Selection 3. PCA Titration 4. Co-Analgesics 5. Breakthrough

More information

(30689) PROT Pain PCA Adult Patient Controlled Analgesia

(30689) PROT Pain PCA Adult Patient Controlled Analgesia Diagnosis Allergies Nursing Assess and Document PCA: 1. Assess and document pain rating, sedation level and respiratory rate every 2 hours; assess and document pain rating, sedation level and respiratory

More information

FREQUENTLY ASKED QUESTIONS

FREQUENTLY ASKED QUESTIONS FREQUENTLY ASKED QUESTIONS Frequently Asked Questions: Table of Contents How should pain be assessed in an unconscious patient? What is the cardiovascular risk associated with the use of nsnsaids/coxibs

More information

6/6/2018. Nalbuphine: Analgesic with a Niche. Mellar P Davis MD FCCP FAAHPM. Summary of Advantages. Summary of Advantages

6/6/2018. Nalbuphine: Analgesic with a Niche. Mellar P Davis MD FCCP FAAHPM. Summary of Advantages. Summary of Advantages Nalbuphine: Analgesic with a Niche Mellar P Davis MD FCCP FAAHPM 1 Summary of Advantages Safe in renal failure- fecal excretion Analgesia equal to morphine with fewer side effects Reduced constipation

More information

3/3/2015 CHRONIC PAIN MARGARET ZOELLERS, MSN, APRN

3/3/2015 CHRONIC PAIN MARGARET ZOELLERS, MSN, APRN CHRONIC PAIN MARGARET ZOELLERS, MSN, APRN 1 Pain that persists or recurs > 3-6 months Pain that persists >1 month after injury/event Commonly seems out of proportion to the physical process Cause may be

More information

OST. Pharmacology & Therapeutics. Leo O. Lanoie, MD, MPH, FCFP, CCSAM, ABAM, MRO

OST. Pharmacology & Therapeutics. Leo O. Lanoie, MD, MPH, FCFP, CCSAM, ABAM, MRO OST Pharmacology & Therapeutics Leo O. Lanoie, MD, MPH, FCFP, CCSAM, ABAM, MRO Disclaimer In the past two years I have received no payment for services from any agency other than government or academic.

More information

ORAL TRANSMUCOSAL AND NASAL FENTANYL UTILIZATION MANAGEMENT CRITERIA

ORAL TRANSMUCOSAL AND NASAL FENTANYL UTILIZATION MANAGEMENT CRITERIA ORAL TRANSMUCOSAL AND NASAL FENTANYL UTILIZATION MANAGEMENT CRITERIA DRUG CLASS: BRAND (generic) NAMES: Fentanyl by oral transmucosal and nasal delivery Actiq (fentanyl citrate) lozenge on a handle 200,

More information

Narcotic Equivalence Converter Narcotic Route Dose Duration; Select a drug: mg Convert to: mg Adapted from Tarascon Pocket Pharmacopoeia.

Narcotic Equivalence Converter Narcotic Route Dose Duration; Select a drug: mg Convert to: mg Adapted from Tarascon Pocket Pharmacopoeia. Narcotic Equivalence Converter Narcotic Route Dose Duration; Select a drug: mg Convert to: mg Adapted from Tarascon Pocket Pharmacopoeia. Created: Monday, March 12. Online calculator to convert equianalgesic

More information

Objectives. Controversy. Pain. Risk Stratification 1/7/2012

Objectives. Controversy. Pain. Risk Stratification 1/7/2012 Objectives Strategies in Pain Management: Scheduled, Breakthrough, and Dose Adjustments Tamara M. Green, Pharm.D PGY-1 Resident Florida A & M University Classify and distinguish between different types

More information

What Do You Mean The Morphine Isn t Working? Objectives. Opioid Epidemic. Ellen Fulp, PharmD, BCGP Clinical Education Coordinator AvaCare, Inc.

What Do You Mean The Morphine Isn t Working? Objectives. Opioid Epidemic. Ellen Fulp, PharmD, BCGP Clinical Education Coordinator AvaCare, Inc. What Do You Mean The Morphine Isn t Working? Ellen Fulp, PharmD, BCGP Clinical Education Coordinator AvaCare, Inc. 42 nd Annual Hospice & Palliative Care Conference September 2018 Charlotte, NC Objectives

More information

EFFECTIVE SHARED CARE AGREEMENT. Dronedarone - For the treatment and management of atrial fibrillation

EFFECTIVE SHARED CARE AGREEMENT. Dronedarone - For the treatment and management of atrial fibrillation EFFECTIVE SHARED CARE AGREEMENT Dronedarone - For the treatment and management of atrial fibrillation Specialist details Patient identifier Name INTRODUCTION This shared care agreement outlines how the

More information

INITIATING THERAPY, MODIFYING DOSING, & DISCONTINUING USE OF ER/LA OPIOID ANALGESICS

INITIATING THERAPY, MODIFYING DOSING, & DISCONTINUING USE OF ER/LA OPIOID ANALGESICS INITIATING THERAPY, MODIFYING DOSING, & DISCONTINUING USE OF ER/LA OPIOID ANALGESICS Unit II R. Corey Waller, MD, MS, FACEP Disclosure of Relevant Financial Relationships Content of Activity: ASAM Medical

More information

Comedy of Errors: Methadone and Buprenorphine

Comedy of Errors: Methadone and Buprenorphine Comedy of Errors: Methadone and Buprenorphine Douglas Gourlay MD, MSc, FRCP(C), DFASAM Disclosures Nothing to disclosure 2 1 Learning Objectives Explain the pharmacology of methadone and buprenorphine

More information

Practical Tools to Successfully Taper Prescription Opioids. Melissa Weimer, DO, MCR

Practical Tools to Successfully Taper Prescription Opioids. Melissa Weimer, DO, MCR Practical Tools to Successfully Taper Prescription Opioids Melissa Weimer, DO, MCR Objectives Understand how to calculate morphine equivalents per day Understand the steps necessary to plan a successful

More information

Pain Management in Hospice and Palliative Care

Pain Management in Hospice and Palliative Care Pain Management in Hospice and Palliative Care A Case-based Approach JoAnne Nowak, M.D. Merrimack Valley Hospice Revised November 2011 Objectives Use a case study approach to stimulate discussion and illustrate

More information

Lumbar Fusion. Reference Guide for PACU CLINICAL PATHWAY. All patient variances to the pathway are to be circled and addressed in the progress notes.

Lumbar Fusion. Reference Guide for PACU CLINICAL PATHWAY. All patient variances to the pathway are to be circled and addressed in the progress notes. Reference Guide for PACU Lumbar Fusion CLINICAL PATHWAY All patient variances to the pathway are to be circled and addressed in the progress notes. This Clinical Pathway is intended to assist in clinical

More information

12/19/16. Disclosures

12/19/16. Disclosures @atriumrx Don t Miss a Beat! Practical Tips on Managing Drug-Induced QTc Prolongation Sandeep Devabhakthuni, PharmD, BCPS- AQ Cardiology Assistant Professor University of Maryland School of Pharmacy Disclosures

More information

2017 Opioid Prescribing Module 401 N. Ewing St. Lancaster, Ohio (740) ~

2017 Opioid Prescribing Module 401 N. Ewing St. Lancaster, Ohio (740) ~ 2017 Opioid Prescribing Module 401 N. Ewing St. Lancaster, Ohio 43130 (740) 687-8000 ~ www.fmchealth.org Introduction The purpose of this module is to reduce the risk of adverse outcomes for adult patients

More information

OPIOID- INDUCED NEUROTOXICITY*

OPIOID- INDUCED NEUROTOXICITY* OPIOID- INDUCED NEUROTOXICITY* Sriram Yennu MD, MS, FAAHPM Palliative Care, Rehabilitation and Integrative Medicine U.T. M.D. Anderson Cancer Center *Slide Deck courtesy Dept PRIM MDACC PATIENT #1: MRS

More information

morphine 30 mg/ 30 ml (1 mg/ml) Opioid of choice

morphine 30 mg/ 30 ml (1 mg/ml) Opioid of choice PATIENT CONTROLLED ANALGESIA (PCA) PLAN Allergies: Medication Selection: morphine 30 mg/ 30 ml (1 mg/ml) Opioid of choice HYDROmorphone (Dilaudid ) 6 mg/ 30 ml (0.2 mg/ml) fentanyl 300 mcg/ 30 ml (10 mcg/ml)

More information

EFFECTIVE SHARED CARE AGREEMENT. July Dronedarone (Multaq ) For the treatment and management of atrial fibrillation

EFFECTIVE SHARED CARE AGREEMENT. July Dronedarone (Multaq ) For the treatment and management of atrial fibrillation Whipps Cross University Hospital NHS Trust EFFECTIVE SHARED CARE AGREEMENT July 2011 Dronedarone (Multaq ) For the treatment and management of atrial fibrillation INTRODUCTION The Whipps Cross University

More information

Palliative Care and the Critical Role of the Pharmacist. Arti Thakerar Education/ Palliative Care Peter MacCallum Cancer Centre

Palliative Care and the Critical Role of the Pharmacist. Arti Thakerar Education/ Palliative Care Peter MacCallum Cancer Centre Palliative Care and the Critical Role of the Pharmacist Arti Thakerar Education/ Palliative Care Peter MacCallum Cancer Centre Overview What is palliative care Role of a pharmacist in palliative care Issues

More information

Amber D. Hartman, PharmD Specialty Practice Pharmacist James Cancer Center & Solove Research Institute Ohio State University Medical Center

Amber D. Hartman, PharmD Specialty Practice Pharmacist James Cancer Center & Solove Research Institute Ohio State University Medical Center Pharmacologic Management of Pain Amber D. Hartman, PharmD Specialty Practice Pharmacist James Cancer Center & Solove Research Institute Ohio State University Medical Center Objectives Identify types of

More information

PAIN CONSIDERATIONS IN PALLIATIVE CARE

PAIN CONSIDERATIONS IN PALLIATIVE CARE PAIN CONSIDERATIONS IN PALLIATIVE CARE Eric Anderson, MD, Palliative Medicine United Hospital September 22, 2017 DISCLOSURE The presenter has no financial relationships to disclose. OBJECTIVES 1. Name

More information

PALLIATIVE TREATMENT BY DR. KHRONGKAMOL SIHABAN MEDICAL ONCOLOGIST

PALLIATIVE TREATMENT BY DR. KHRONGKAMOL SIHABAN MEDICAL ONCOLOGIST PALLIATIVE TREATMENT BY DR. KHRONGKAMOL SIHABAN MEDICAL ONCOLOGIST TREATMENT IN ONCOLOGY Main treatment : surgery Neoadjuvant treatment : RT, CMT Adjuvant treatment : Tx micrometastatic disease -CMT,Targeted

More information

GUIDELINES AND AUDIT IMPLEMENTATION NETWORK

GUIDELINES AND AUDIT IMPLEMENTATION NETWORK GUIDELINES AND AUDIT IMPLEMENTATION NETWORK General Palliative Care Guidelines The Management of Pain at the End Of Life November 2010 Aim To provide a user friendly, evidence based guide for the management

More information

BJF Acute Pain Team Formulary Group

BJF Acute Pain Team Formulary Group Title Analgesia Guidelines for Acute Pain Management (Adults) in BGH Document Type Issue no Clinical guideline Clinical Governance Support Team Use Issue date April 2013 Review date April 2015 Distribution

More information

Pain in advanced illness

Pain in advanced illness Methadone: Safe and Effective Use for Hospice Pain Management for Adult and Pediatric Patients Nathaniel Hedrick, PharmD ProCare HospiceCare Clinical Pharmacist Nhedrick@procarerx.com Jeremy L. Brown,

More information

Interprofessional Webinar Series

Interprofessional Webinar Series Interprofessional Webinar Series Opioids in the Medically Ill: Principles of Administration Russell K. Portenoy, MD Chief Medical Officer MJHS Hospice and Palliative Care Director MJHS Institute for Innovation

More information

Neuropathic Pain Treatment Guidelines

Neuropathic Pain Treatment Guidelines Neuropathic Pain Treatment Guidelines Background Pain is an unpleasant sensory and emotional experience that can have a significant impact on a person s quality of life, general health, psychological health,

More information

Drug Information Common to the Class of Extended-Release and Long-Acting Opioid Analgesics (ER/LA opioid analgesics) Avinza Butrans

Drug Information Common to the Class of Extended-Release and Long-Acting Opioid Analgesics (ER/LA opioid analgesics) Avinza Butrans FDA Blueprint for Prescriber Education for Extended-Release and Long-Acting Opioid Analgesics 7/9/2012 Drug Information Common to the Class of Extended-Release and Long-Acting Opioid Analgesics (ER/LA

More information

Oxycontin conversion to ms contin

Oxycontin conversion to ms contin Oxycontin conversion to ms contin The Borg System is 100 % Oxycontin conversion to ms contin Ms contin to morphine conversion MS Contin is. The patient s current dose of 240 mg per day of oral oxycodone

More information

Pain Management: The Use of Methadone in Hospice and Palliative Care. By: Kiran Hamid, RPh August 16, 2018.

Pain Management: The Use of Methadone in Hospice and Palliative Care. By: Kiran Hamid, RPh August 16, 2018. Pain Management: The Use of Methadone in Hospice and Palliative Care By: Kiran Hamid, RPh August 16, 2018. Conflict of Interest and Disclosures of Relevant Financial Relationships The planners and presenters

More information

OAT Transitions - focus on microdosing. Mark McLean MD MSc FRCPC CISAM DABAM

OAT Transitions - focus on microdosing. Mark McLean MD MSc FRCPC CISAM DABAM OAT Transitions - focus on microdosing Mark McLean MD MSc FRCPC CISAM DABAM Disclosures No pharmaceutical industry or other financial conflicts of interest Study Physician for research funded by Canadian

More information

Complex Pain: Methadone

Complex Pain: Methadone Frontiers in Palliative Medicine Colorado, November 2017 Complex Pain: Methadone Frank D Ferris, MD, FAAHPM, FAACE Continuing Education Disclosures Approval Statement: The University of Colorado College

More information

What s New 2003? What new treatments? What have you discontinued? More information please!

What s New 2003? What new treatments? What have you discontinued? More information please! What s New 2003? What new treatments? What have you discontinued? More information please! 1 What s New 2003? Submissions = 137 UK = 52 (38%) Doctors = 60% Nurses = 25% Pharmacists = 15% 2 What s New?

More information

Arresting Pain without Getting Arrested

Arresting Pain without Getting Arrested G. Jay Westbrook, M.S., R.N., CHPN - Clinical Director Compassionate Journey: An End-of-Life Clinical & Education Service CompassionateJourney@hotmail.com 818/773-3700 Arresting Pain without Getting Arrested

More information

NEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES

NEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES NEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES GENERAL PRINCIPLES Neuropathic pain may be relieved in the majority of patients by multimodal management A careful history and examination are essential.

More information

E-Learning Module N: Pharmacological Review

E-Learning Module N: Pharmacological Review E-Learning Module N: Pharmacological Review This Module requires the learner to have read Chapter 13 of the Fundamentals Program Guide and the other required readings associated with the topic. Revised:

More information

Pain is a more terrible Lord of mankind than even death itself.

Pain is a more terrible Lord of mankind than even death itself. CHRONIC OPIOID RX FOR NON-MALIGNANT PAIN Gerald M. Aronoff, M.D., DABPM Med. Dir., Carolina Pain Assoc Charlotte, North Carolina, USA Pain Pain is a more terrible Lord of mankind than even death itself.

More information

ANTICIPATORY PRESCRIBING FOR PATIENTS AT END OF LIFE WITH RENAL IMPAIRMENT

ANTICIPATORY PRESCRIBING FOR PATIENTS AT END OF LIFE WITH RENAL IMPAIRMENT ANTICIPATORY PRESCRIBING FOR PATIENTS AT END OF LIFE WITH RENAL Doses of opiates must be proptional to current analgesic medication Please refer ALL patients on Methadone Ketamine to SPCT f advice. Patients

More information

Agonists: morphine, fentanyl Agonists-Antagonists: nalbuphine Antagonists: naloxone

Agonists: morphine, fentanyl Agonists-Antagonists: nalbuphine Antagonists: naloxone Opioid Definition All drugs, natural or synthetic, that bind to opiate receptors Agonists: morphine, fentanyl Agonists-Antagonists: nalbuphine Antagonists: naloxone Opioid agonists increase pain threshold

More information

Best Practices in Prescribing Opioids for Chronic Non-cancer Pain

Best Practices in Prescribing Opioids for Chronic Non-cancer Pain Best Practices in Prescribing Opioids for Chronic Non-cancer Pain Disclosures S C O T T S T E I G E R, M D, F A C P, D A B A M A S S I S T A N T C L I N I C A L P R O F E S S O R D I V I S I O N O F G

More information

Immodium / loprarmide

Immodium / loprarmide Immodium / loprarmide IMODIUM (loperamide hydrochloride) is indicated for the control and symptomatic relief of acute nonspecific diarrhea and of chronic diarrhea associated with inflammatory bowel disease.

More information

PRESCRIBING PRACTICE IN DELIRIUM. John Warburton Critical Care Pharmacist

PRESCRIBING PRACTICE IN DELIRIUM. John Warburton Critical Care Pharmacist PRESCRIBING PRACTICE IN DELIRIUM John Warburton Critical Care Pharmacist Learning outcomes Modifiable medication risk factors for delirium An appreciation of contributing factors modifiable with medicines

More information